牙龈素在心血管疾病中致病机制的研究进展

doi:10.13701/j.cnki.kqyxyj.2025.07.001

摘要/Abstract

摘要： 牙龈素是由牙周炎主要致病菌牙龈卟啉单胞菌分泌的一种特殊蛋白酶。它不仅破坏牙周组织,而且能由受损的牙龈进入血液,扩散到远端器官,直接损伤心血管组织。此外,它还通过引发机体的免疫反应,导致全身轻度炎症,间接影响心血管疾病的发生发展。本文综述了牙龈素的生物学特征,其在心血管疾病中的致病机制,以及在牙周炎与心血管疾病相互影响中的作用,旨在为全面认知牙龈素在心血管疾病的致病机制提供基础。

关键词: 牙龈素, 牙龈卟啉单胞菌, 心血管疾病, 致病机制, 牙周炎

Abstract: Gingipain is a special protease secreted by Porphyromonas gingivalis, the main pathogen of periodontitis. It not only destroys periodontal tissues, but also enters the blood from damaged gums, spreads to distal organs, and directly damages cardiovascular tissues. In addition, it also indirectly affects the occurrence and development of cardiovascular diseases by inducing the body's immune response and causing mild systemic inflammation. This article reviews the biological characteristics of gingipain, its pathogenic mechanism in cardiovascular diseases, and its role in the interaction between periodontitis and cardiovascular diseases, aiming to provide a basis for a comprehensive understanding of the pathogenic mechanism of cardiovascular diseases.

Key words: gingipain, Porphyromonas gingivalis, cardiovascular disease, disease pathogenesis, periodontitis

熊曼雯, 刘敏. 牙龈素在心血管疾病中致病机制的研究进展[J]. 口腔医学研究, 2025, 41(7): 547-551.

XIONG Manwen, LIU Min. Research Progress on Pathogenic Mechanism of Gingipain in Cardiovascular Diseases[J]. Journal of Oral Science Research, 2025, 41(7): 547-551.

参考文献

[1] Vaduganathan M, Mensah GA, Turco JV, et al. The global burden of cardiovascular diseases and risk: A compass for future health [J]. J Am Coll Cardiol, 2022, 80(25):2361-2371.
[2] Crea F. Challenges in the prevention of cardiovascular diseases: traditional and non-traditional risk factors [J]. Eur Heart J, 2021, 42(21):2025-2029.
[3] Altamura S, Del Pinto R, Pietropaoli D, et al. Oral health as a modifiable risk factor for cardiovascular diseases [J]. Trends Cardiovasc Med, 2024, 34(4):267-275.
[4] Qiu Q, Zhang F, Wu J, et al. Gingipains disrupt F-actin and cause osteoblast apoptosis via integrin β1 [J]. J Periodontal Res, 2018, 53(5):762-776.
[5] Aleksijević LH, Aleksijević M, Škrlec I, et al. Porphyromonas gingivalis virulence factors and clinical significance in periodontal disease and coronary artery diseases [J]. Pathogens, 2022, 11(10):1173.
[6] Chow YC, Yam HC, Gunasekaran B, et al. Implications of Porphyromonas gingivalis peptidyl arginine deiminase and gingipain R in human health and diseases [J]. Front Cell Infect Microbiol, 2022, 12:987683.
[7] Nowakowska Z, Madej M, Grad S, et al. Phosphorylation of major Porphyromonas gingivalis virulence factors is crucial for their processing and secretion [J]. Mol Oral Microbiol, 2021, 36(6):316-326.
[8] 汪丹,孟维艳.牙龈卟啉单胞菌牙龈蛋白酶的研究进展[J].口腔医学研究,2022,38(3):216-219.
[9] Nonaka S, Kadowaki T, Nakanishi H. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins [J]. Neurochem Int, 2022, 154:105282.
[10] Elashiry M, Carroll A, Yuan J, et al. Oral microbially-induced small extracellular vesicles cross the blood-brain barrier [J]. Int J Mol Sci, 2024, 25(8):4509.
[11] Lei S, Li J, Yu J, et al. Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway [J]. Int J Oral Sci, 2023, 15(1):3.
[12] Li F, Ma C, Lei S, et al. Gingipains may be one of the key virulence factors of Porphyromonas gingivalis to impair cognition and enhance blood-brain barrier permeability: An animal study [J]. J Clin Periodontol, 2024, 51(7):818-839.
[13] Farrugia C, Stafford GP, Potempa J, et al. Mechanisms of vascular damage by systemic dissemination of the oral pathogen Porphyromonas gingivalis [J]. FEBS J, 2021, 288(5):1479-1495.
[14] Sasaki N, Takeuchi H, Kitano S, et al. Dynamic analysis of Porphyromonas gingivalis invasion into blood capillaries during the infection process in host tissues using a vascularized three-dimensional human gingival model [J]. Biomater Sci, 2021, 9(19):6574-6583.
[15] Zou Z, Fang J, Ma W, et al. Porphyromonas gingivalis gingipains destroy the vascular barrier and reduce CD99 and CD99L2 expression to regulate transendothelial migration [J]. Microbiol Spectr, 2023, 11(3):e0476922.
[16] Nunes JM, Fillis T, PAge MJ, et al. Gingipain R1 and lipopolysaccharide from Porphyromonas gingivalis have major effects on blood clot morphology and mechanics [J]. Front Immunol, 2020, 11:1551.
[17] Freiherr Von Seckendorff A, Nomenjanahary MS, Labreuche J, et al. Periodontitis in ischemic stroke:impact of Porphyromonas gingivalis on thrombus composition and ischemic stroke outcomes [J]. Res Pract Thromb Haemost, 2024, 8(1):102313.
[18] Shiheido-Watanabe Y, Maejima Y, Nakagama S, et al. Porphyromonas gingivalis,a periodontal pathogen, impairs post-infarcted myocardium by inhibiting autophagosome-lysosome fusion [J]. Int J Oral Sci, 2023, 15(1):42.
[19] Wadhawan A, Reynolds MA, Makkar H, et al. Periodontal pathogens and neuropsychiatric health [J]. Curr Top Med Chem, 2020, 20(15):1353-1397.
[20] Cichońska D, Mazuś M, Kusiak A. Recent aspects of periodontitis and Alzheimer's disease-A narrative review [J]. Int J Mol Sci, 2024, 25(5):2612.
[21] Køllgaard T, Enevold C, Bendtzen K, et al. Cholesterol crystals enhance TLR2- and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis [J]. PLoS One, 2017, 12(2):e0172773.
[22] Yamaguchi Y, Kurita-Ochiai T, Kobayashi R, et al. Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis [J]. Pathog Dis, 2015, 73(4):ftv011.
[23] Lunar Silva I, Cascales E. Molecular strategies underlying Porphyromonas gingivalis virulence [J]. J Mol Biol, 2021, 433(7):166836.
[24] Martins CC, Lockhart PB, Firmino RT, et al. Bacteremia following different oral procedures: Systematic review and meta-analysis [J]. Oral Dis, 2024, 30(3):846-854.
[25] Wang J, Zhou Y, Ren B, et al. The role of neutrophil extracellular traps in periodontitis [J]. Front Cell Infect Microbiol, 2021, 11:639144.
[26] Geng X, Wang DW, Li H. The pivotal role of neutrophil extracellular traps in cardiovascular diseases:Mechanisms and therapeutic implications [J]. Biomed Pharmacother, 2024, 179:117289.
[27] Bryzek D, Ciaston I, Dobosz E, et al. Triggering NETosis via protease-activated receptor (PAR)-2 signaling as a mechanism of hijacking neutrophils function for pathogen benefits [J]. PLoS Pathog, 2019, 15(5):e1007773.
[28] Qu H, Zhang S. Association of cardiovascular health and periodontitis: a population-based study [J]. BMC Public Health, 2024, 24(1):438.
[29] Bassani B, Cucchiara M, Butera A, et al. Neutrophils' contribution to periodontitis and periodontitis-associated cardiovascular diseases [J]. Int J Mol Sci, 2023, 24(20):15370.
[30] Sanz M, Marco Del Castillo A, Jepsen S, et al. Periodontitis and cardiovascular diseases:Consensus report [J]. J Clin Periodontol, 2020, 47(3):268-288.
[31] Men B, Li Y, Jiang S. Updates on the role of periodontitis-related epigenetics, inflammation, oral microbiome, and treatment in cardiovascular risk [J]. J Inflamm Res, 2024, 17:837-851.
[32] 孟焕新.牙周病学[M].第5版.北京:人民卫生出版,2020, 183-183.